Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

XCUR

Exicure Inc

Jul 26 • 04:00PM ET

0.4800

Dollar change -0.0200
Percentage change -4.00	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.56	Insider Own	48.11%	Shs Outstand	8.65M	Perf Week	-10.30%
Market Cap	4.15M	Forward P/E	-	EPS next Y	-	Insider Trans	-44.96%	Shs Float	4.49M	Perf Month	52.77%
Income	-13.34M	PEG	-	EPS next Q	-	Inst Own	4.03%	Short Float	2.79%	Perf Quarter	-5.70%
Sales	0.50M	P/S	8.30	EPS this Y	-	Inst Trans	-0.95%	Short Ratio	0.12	Perf Half Y	-9.94%
Book/sh	0.26	P/B	1.88	EPS next Y	-	ROA	-76.97%	Short Interest	0.13M	Perf Year	-53.85%
Cash/sh	0.04	P/C	11.22	EPS next 5Y	-	ROE	-158.52%	52W Range	0.29 - 1.14	Perf YTD	-17.28%
Dividend Est.	-	P/FCF	-	EPS past 5Y	33.58%	ROI	-165.66%	52W High	-57.89%	Beta	1.15
Dividend TTM	-	Quick Ratio	0.55	Sales past 5Y	1609.08%	Gross Margin	-129.00%	52W Low	64.72%	ATR (14)	0.10
Dividend Ex-Date	-	Current Ratio	0.55	EPS Y/Y TTM	-610.11%	Oper. Margin	-2074.60%	RSI (14)	60.20	Volatility	53.87% 22.42%
Employees	6	Debt/Eq	2.94	Sales Y/Y TTM	-98.10%	Profit Margin	-2667.20%	Recom	3.00	Target Price	2.00
Option/Short	No / No	LT Debt/Eq	2.64	EPS Q/Q	86.33%	Payout	-	Rel Volume	1.04	Prev Close	0.50
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	May 16 AMC	Avg Volume	1.02M	Price	0.48
SMA20	36.24%	SMA50	24.62%	SMA200	-11.35%	Trades		Volume	1,055,663	Change	-4.00%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-21	Downgrade	Chardan Capital Markets	Buy → Neutral	$2.25 → $0.40
Dec-18-20	Initiated	BMO Capital Markets	Outperform	$6
Nov-20-19	Initiated	Guggenheim	Buy	$9

Today 07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-17-24 09:53PM	XCUR Stock Earnings: Exicure Reported Results for Q1 2024 (InvestorPlace)
04:01PM	Exicure, Inc. Reports First Quarter 2024 Financial Results (Business Wire)
Jun-06-24 09:52PM	XCUR Stock Earnings: Exicure Reported Results for Q4 2023 (InvestorPlace) -5.30% -16.35%
04:01PM	Exicure, Inc. Reports Full Year 2023 Financial Results (Business Wire)
07:39AM	Loading…
May-29-24 07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +11.05%
May-23-24 04:01PM	Exicure, Inc. Received Nasdaq Notice of a Delisting Determination (Business Wire) -26.34%
May-16-24 09:52PM	XCUR Stock Earnings: Exicure Reported Results for Q3 2023 (InvestorPlace)
04:08PM	Exicure, Inc. Reports Third Quarter 2023 Financial Results (Business Wire)
Apr-22-24 04:01PM	Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K (Business Wire)
Feb-06-24 07:05AM	Exicure and Bluejay sign hepatitis treatment development deal (Pharmaceutical Business Review) +27.59%
Feb-05-24 04:01PM	Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis (Business Wire)
Dec-08-23 08:40AM	Why Is Exicure (XCUR) Stock Up 57% Today? (InvestorPlace) +28.59%
Nov-28-23 04:01PM	Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q (Business Wire) -6.00%
Aug-23-23 09:48AM	Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors (Business Wire)
04:01PM	Loading…
Aug-11-23 04:01PM	Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update (Business Wire)
Jul-14-23 04:01PM	Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update (Business Wire) +7.94%
May-26-23 04:01PM	Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives (Business Wire)
May-19-23 04:01PM	Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q (Business Wire) -9.13%
May-04-23 04:01PM	Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld (Business Wire)
Apr-27-23 07:00AM	Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors (Business Wire)
Mar-27-23 04:01PM	Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update (Business Wire) -5.26% -10.84%
Feb-24-23 05:10PM	Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors (Business Wire) +7.02%
Dec-14-22 05:00AM	Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements (Business Wire)
Nov-14-22 04:01PM	Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update (Business Wire) -8.73%
Sep-26-22 04:01PM	Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives (Business Wire) +10.39% -17.06%
Sep-01-22 07:00AM	Exicure Announces Presentation at Chardans 6th Annual Genetic Medicines Conference (Business Wire)
Aug-15-22 04:01PM	Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress (Business Wire)
Jul-20-22 04:01PM	Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire)
Jun-29-22 12:00PM	Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split (Business Wire) -27.81%
04:01PM	Loading…
May-27-22 04:01PM	Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders (Business Wire) +6.69%
May-17-22 07:00AM	Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference (Business Wire) +9.21%
May-16-22 04:01PM	Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress (Business Wire) -6.19%
May-10-22 07:21PM	Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium (Business Wire) +6.19% +7.24%
May-09-22 07:00AM	Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference (Business Wire) -19.21%
Mar-25-22 04:15PM	Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress (Business Wire) -16.69% -24.15%
Feb-04-22 11:25AM	Chicago CEO steps down after just two months on the job (American City Business Journals)
07:00AM	Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors (Business Wire)
Jan-05-22 01:38PM	Neville Rodie & Shaw Inc Buys Cleveland-Cliffs Inc, Palo Alto Networks Inc, Novo Nordisk ... (GuruFocus.com) -9.05%
Dec-31-21 07:07PM	Upcoming Deadline Reminder: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire) +11.38%
06:02PM	Exicure Class Action Reminder (NewMediaWire)
02:53PM	UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (PR Newswire)
01:15PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-30-21 05:57PM	Exicure Shareholder Notice (NewMediaWire)
03:31PM	Shareholder Action Notice: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:00AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-29-21 11:46PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exicure, Inc. - XCUR (PR Newswire) -8.95%
05:57PM	Exicure Shareholder Alert (NewMediaWire)
04:30PM	Shareholder Action Alert: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:45AM	INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-28-21 05:57PM	Exicure Deadline Alert (NewMediaWire)
02:50PM	Investor Action Reminder: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:00AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-27-21 03:16PM	Shareholder Action Notice: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
11:00AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-26-21 08:32AM	Exicure Class Action Reminder (NewMediaWire)
Dec-24-21 06:13PM	Exicure Shareholder Notice (NewMediaWire)
01:56PM	Shareholder Action Alert: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
10:40AM	INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-23-21 08:38PM	ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Exicure, Inc. Investors with Losses to Secure Counsel Before Important February 11 Deadline in Securities Class Action - XCUR (PR Newswire)
09:30AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-22-21 06:22PM	Bill Gates Slashes Investment in This Penny Biotech Stock (Barrons.com) -7.40%
05:59PM	Exicure Shareholder Notice (NewMediaWire)
04:50PM	Shareholder Action Notice: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
02:32PM	DEADLINE ALERT for RVNC, RAAS, ORGO, and XCUR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders (GlobeNewswire)
11:00AM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm (ACCESSWIRE)
10:00AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-21-21 05:54PM	Exicure Shareholder Alert (NewMediaWire)
04:08PM	Shareholder Action Alert: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
11:00AM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (Business Wire)
09:30AM	INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
07:38AM	XCUR Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Exicure, Inc. (XCUR) (Business Wire)
Dec-20-21 05:47PM	Exicure Deadline Alert (NewMediaWire)
03:49PM	Investor Action Reminder: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
11:00AM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Investors to Contact the Firm (ACCESSWIRE)
11:00AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
10:00AM	Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR) (Business Wire)
Dec-19-21 09:00PM	EXICURE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Exicure, Inc. and Encourages Investors to Contact the Firm (GlobeNewswire)
08:32AM	Exicure Notice To Shareholders (NewMediaWire)
Dec-17-21 06:13PM	Exicure Class Action Reminder (NewMediaWire)
05:00PM	Contact Firm: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
01:40PM	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Exicure, Inc. Investors to Secure Counsel Before Important February 11 Deadline in Securities Class Action XCUR (Business Wire)
12:32PM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (GlobeNewswire)
09:45AM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-16-21 03:50PM	INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
03:00PM	XCUR INVESTOR NOTICE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Exicure, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action XCUR (GlobeNewswire)
11:00AM	XCUR Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (ACCESSWIRE)
11:00AM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exicure, Inc. (XCUR) (Business Wire)
12:49AM	INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (NewMediaWire)
Dec-15-21 05:59PM	EXICURE SHAREHOLDER NOTICE (NewMediaWire)
04:00PM	XCUR Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Exicure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (PR Newswire)
01:36PM	XCUR SHAREHOLDERS: Robbins LLP Informs Investors of Class Action Against Exicure, Inc. (XCUR) (Business Wire)
12:15PM	The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Exicure, Inc. (XCUR) Investors (Business Wire)
09:10AM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (ACCESSWIRE)
Dec-14-21 09:00PM	EXICURE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Exicure, Inc. and Encourages Investors to Contact the Firm (GlobeNewswire) -6.29%
01:53PM	Exicure, Inc. Announces $11.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (Business Wire)
12:45PM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Exicure, Inc. (XCUR) Investigation (ACCESSWIRE)
10:12AM	EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Exicure, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action XCUR (Business Wire)
09:34AM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm (Business Wire)
Dec-13-21 10:00PM	EXICURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Exicure, Inc. and Encourages Investors to Contact the Firm (Business Wire) -40.68%

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DGP Co., Ltd.	10% Owner	Feb 29 '24	Sale	1.32	3,400,000	4,488,000	0	Mar 04 06:36 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

XCUR

Exicure Inc

Upgrade your FINVIZ experience